Delivery Method: UPS Reference #: 320-19-15 Product: Drugs Recipient: Recipient Name Mr. Pramod Yadav Recipient Title Chief Executive Officer Jubilant Generics Limited 1A, Sector 16ANoida 201301Uttar […]

Rogue online pharmacies offer potentially dangerous prescription drugs to U.S. consumers. FDA has issued warning letters informing the website operators that they are engaged in illegal […]

For Immediate Release: April 30, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the […]

Summary Company Announcement Date: July 09, 2020 FDA Publish Date: July 24, 2020 Product Type: Drugs Reason for Announcement: Recall Reason Description Potential presence of methanol […]

Summary Company Announcement Date: August 30, 2023 FDA Publish Date: August 31, 2023 Product Type: Drugs Reason for Announcement: Recall Reason Description Label Mix-Up Company Name: […]

Drugs to Which FDA has Granted Pediatric Exclusivity for Pediatric Studies under Section 505A of the Federal Food, Drug, and Cosmetic Act NOTE: This list simply identifies […]

Product: Drugs Recipient: www.dashpct.com Malaysia Issuing Office: Center for Drug Evaluation and Research | CDER United States FROM: The United States Food and Drug Administration RE: […]

The Inactive Ingredients files are supplied as comma delimited text and Excel files. The size of each unzipped file is less than 2 MB. We update […]

Tivdak (tisotumab vedotin-tftv) Treatment of adult patients with recurrent or metastatic cervical cancer with disease progression on or after chemotherapy 9/20/2021 4/29/2024 Elahere (mirvetuximab soravtansine-gynx) Adult […]